Lilly's massive R&D budget has also allowed it to focus on retatrutide, a so-called "triple-agonist" combining GLP-1 properties with other medications, that is currently in trial.
Researchers derived this compound from a naturally occurring protein found in human gastric juice
Diabetologia 65(Suppl 1):S290S291 Gastaldelli A, Cusi K, Fernandez Lando L, Bray R, Brouwers B, Rodriguez A (2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
In the nearer term, disability income claimants with sustained weight loss could demonstrate an increase in functional capacity, including the ability to return to work
J Am Coll Cardiol 2024;84:27-40.PubMed 96
In the context of skin health, glutathione is highly valued for its ability to regulate pigment